...
search icon
skye-img

Skye Bioscience, Inc. Common Stock Share Price

SKYE
NMQ
$0.7238
+$0
(0%)
1D
Industry: Biotechnology Sector: Health Care

Skye Bioscience, Inc. Common Stock Analyst Forecast

Skye Bioscience, Inc. Common Stock Share Price Chart

Skye Bioscience, Inc. Common Stock Key Stock Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$23.11M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
87.46K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
2.82
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$0.68 L
$5.75 H
$0.7238

About Skye Bioscience, Inc. Common Stock, Common Stock

Skye Bioscience, Inc., a clinical stage biopharmaceutical company, focuses on developing molecules that modulate G protein-coupled receptors (GPCRs) to treat obesity, overweight, and metabolic diseases. Its lead product candidate is nimacimab, a peripherally restricted negative allosteric modulating antibody targeting cannabinoid receptor 1, a key GPCR involved in metabolic regulation. The company was formerly known as Emerald Bioscience, Inc. and changed its name to Skye Bioscience, Inc. in January 2021. The company is headquartered in San Diego, California. more

Industry: BiotechnologySector: Health Care

Skye Bioscience, Inc. Common Stock Stock Returns

Time FrameSKYESectorS&P500
1-Week Return-11.62%-1.08%-1.38%
1-Month Return-26.14%-0.47%-1.81%
3-Month Return-47.17%2.13%1.38%
6-Month Return-76.95%17.04%5.68%
1-Year Return-76.35%6.56%11.74%
3-Year Return-92.18%16.78%65.15%
5-Year Return-97.77%34.34%73.68%
10-Year Return-99.62%137.88%260.03%

Skye Bioscience, Inc. Common Stock Financials

Dec '20Dec '21Dec '22Dec '23Dec '245YR TREND
Total Revenue-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Cost of Revenue1.87K34.13K115.00K124.25K298.64K[{"date":"2020-12-31","value":0.63,"profit":true},{"date":"2021-12-31","value":11.43,"profit":true},{"date":"2022-12-31","value":38.51,"profit":true},{"date":"2023-12-31","value":41.61,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Gross Profit(1.87K)(34.13K)(115.00K)(124.25K)(298.64K)[{"date":"2020-12-31","value":-187200,"profit":false},{"date":"2021-12-31","value":-3413100,"profit":false},{"date":"2022-12-31","value":-11499800,"profit":false},{"date":"2023-12-31","value":-12425100,"profit":false},{"date":"2024-12-31","value":-29864000,"profit":false}]
Gross Margin-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Operating Expenses6.29M7.85M18.31M34.74M30.19M[{"date":"2020-12-31","value":18.1,"profit":true},{"date":"2021-12-31","value":22.59,"profit":true},{"date":"2022-12-31","value":52.72,"profit":true},{"date":"2023-12-31","value":100,"profit":true},{"date":"2024-12-31","value":86.92,"profit":true}]
Operating Income(6.29M)(7.85M)(18.31M)(34.74M)(30.19M)[{"date":"2020-12-31","value":-628901300,"profit":false},{"date":"2021-12-31","value":-784771400,"profit":false},{"date":"2022-12-31","value":-1831173200,"profit":false},{"date":"2023-12-31","value":-3473517300,"profit":false},{"date":"2024-12-31","value":-3019271800,"profit":false}]
Total Non-Operating Income/Expense(976.36K)(1.44M)(1.93M)(3.71M)5.92M[{"date":"2020-12-31","value":-16.51,"profit":false},{"date":"2021-12-31","value":-24.37,"profit":false},{"date":"2022-12-31","value":-32.62,"profit":false},{"date":"2023-12-31","value":-62.76,"profit":false},{"date":"2024-12-31","value":100,"profit":true}]
Pre-Tax Income(6.56M)(8.52M)(19.47M)(37.64M)(26.56M)[{"date":"2020-12-31","value":-655909900,"profit":false},{"date":"2021-12-31","value":-852008200,"profit":false},{"date":"2022-12-31","value":-1947486100,"profit":false},{"date":"2023-12-31","value":-3764118400,"profit":false},{"date":"2024-12-31","value":-2655705200,"profit":false}]
Income Taxes1.60K2.10K6.74K3.60K10.07K[{"date":"2020-12-31","value":15.89,"profit":true},{"date":"2021-12-31","value":20.85,"profit":true},{"date":"2022-12-31","value":66.93,"profit":true},{"date":"2023-12-31","value":35.75,"profit":true},{"date":"2024-12-31","value":100,"profit":true}]
Income After Taxes(6.56M)(8.52M)(19.48M)(37.64M)(26.57M)[{"date":"2020-12-31","value":-656069900,"profit":false},{"date":"2021-12-31","value":-852218200,"profit":false},{"date":"2022-12-31","value":-1948160200,"profit":false},{"date":"2023-12-31","value":-3764478400,"profit":false},{"date":"2024-12-31","value":-2656712300,"profit":false}]
Income From Continuous Operations(6.56M)(8.52M)(19.48M)(37.64M)(26.57M)[{"date":"2020-12-31","value":-656069900,"profit":false},{"date":"2021-12-31","value":-852218200,"profit":false},{"date":"2022-12-31","value":-1948160200,"profit":false},{"date":"2023-12-31","value":-3764478400,"profit":false},{"date":"2024-12-31","value":-2656712300,"profit":false}]
Income From Discontinued Operations-----[{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true},{"date":"2024-12-31","value":"-","profit":true}]
Net Income(6.56M)(8.52M)(19.48M)(37.64M)(26.57M)[{"date":"2020-12-31","value":-656100000,"profit":false},{"date":"2021-12-31","value":-852218200,"profit":false},{"date":"2022-12-31","value":-1948160200,"profit":false},{"date":"2023-12-31","value":-3764478400,"profit":false},{"date":"2024-12-31","value":-2656712300,"profit":false}]
EPS (Diluted)(0.04)(0.03)(0.04)(3.80)(0.77)[{"date":"2020-12-31","value":-4,"profit":false},{"date":"2021-12-31","value":-3.44,"profit":false},{"date":"2022-12-31","value":-4,"profit":false},{"date":"2023-12-31","value":-380.42,"profit":false},{"date":"2024-12-31","value":-77.12,"profit":false}]

Skye Bioscience, Inc. Common Stock Ratios

Skye Bioscience, Inc. Common Stock Liquidity Ratios

These ratios help you determine the liquidity of the company. Higher is better.

SKYE
Cash Ratio 4.22
Current Ratio 4.77

Skye Bioscience, Inc. Common Stock Asset Efficiency Ratios

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

SKYE
ROA (LTM) -54.88%
ROE (LTM) -94.31%

Skye Bioscience, Inc. Common Stock Liability Ratios

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

SKYE
Debt Ratio Lower is generally better. Negative is bad. 0.21
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.79

Skye Bioscience, Inc. Common Stock Valuation Ratios

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

SKYE
Trailing PE NM
Forward PE NM
P/S (TTM) 0.00
P/B 0.70
Price/FCF NM
EV/R 0.00
EV/Ebitda NM

FAQs

What is Skye Bioscience, Inc. Common Stock share price today?

Skye Bioscience, Inc. Common Stock (SKYE) share price today is $0.7238

Can Indians buy Skye Bioscience, Inc. Common Stock shares?

Yes, Indians can buy shares of Skye Bioscience, Inc. Common Stock (SKYE) on Vested. To buy

from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in SKYE stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Skye Bioscience, Inc. Common Stock be purchased?

Yes, you can purchase fractional shares of Skye Bioscience, Inc. Common Stock (SKYE) via the Vested app. You can start investing in Skye Bioscience, Inc. Common Stock (SKYE) with a minimum investment of $1.

How to invest in Skye Bioscience, Inc. Common Stock shares from India?

You can invest in shares of Skye Bioscience, Inc. Common Stock (SKYE) via Vested in three simple steps:

  • Click on Sign Up or Invest in SKYE stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Skye Bioscience, Inc. Common Stock shares
What is Skye Bioscience, Inc. Common Stock 52-week high and low stock price?

The 52-week high price of Skye Bioscience, Inc. Common Stock (SKYE) is $5.75. The 52-week low price of Skye Bioscience, Inc. Common Stock (SKYE) is $0.68.

What is Skye Bioscience, Inc. Common Stock price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Skye Bioscience, Inc. Common Stock (SKYE) is

What is Skye Bioscience, Inc. Common Stock price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Skye Bioscience, Inc. Common Stock (SKYE) is 0.70

What is Skye Bioscience, Inc. Common Stock dividend yield?

The dividend yield of Skye Bioscience, Inc. Common Stock (SKYE) is 0.00%

What is the Market Cap of Skye Bioscience, Inc. Common Stock?

The market capitalization of Skye Bioscience, Inc. Common Stock (SKYE) is $23.11M

What is Skye Bioscience, Inc. Common Stock's stock symbol?

The stock symbol (or ticker) of Skye Bioscience, Inc. Common Stock is SKYE

How Can Investors Use Skye Bioscience, Inc. Common Stock Share Price Data for Long-Term Investment Decisions?

Consider the share price of Skye Bioscience, Inc. Common Stock as a long-term story and not a daily point list. The price represents a movement of the stock in both good and bad times when looked at over many years. This assists the investors to know whether Skye Bioscience, Inc. Common Stock has succeeded to expand steadily and overcome market declines. With this price movement observed and the way the business is progressing, it is easier to make a decision whether the stock is worth having in the long term or not.

How does USD - INR currency movement impact returns from Skye Bioscience, Inc. Common Stock shares for Indian investors?

When investing in Skye Bioscience, Inc. Common Stock shares, you are not based in India then your investment is not just based on the stock price. It is also determined by the currency movement of the dollar in relation to the rupee. When you have an appreciation of the Skye Bioscience, Inc. Common Stock stock and the dollar appreciation is also the same, you gain more in terms of rupees. When the rupee appreciated, it will lower your profits. This currency flow is a silent cause of great contribution to your ultimate returns over many years.

How should investors compare Skye Bioscience, Inc. Common Stock share price with other stocks in the same sector?

Rather than merely checking the share price of Skye Bioscience, Inc. Common Stock and comparing it with that of other stocks in the same sector, one can check how robust the business is. Investors tend to compare such aspects as profits, cash generation, and the stability of the revenues of the company. This means that Skye Bioscience, Inc. Common Stock stock in most cases does not react in the same manner as other companies in the sector due to its brand and services revenue.

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top